[The management of an adverse event in a paediatric unit]

Emmanuelle Cruz1, Aurélie Dubrulle1

  • 1Service de pédiatrie spécialisée, Hôpital d'enfants de Margency, 18, rue Roger-Salengro, 95580 Margency, France.

Insights

Hospital authorities analyze adverse events to implement corrective measures, aiming to improve patient safety. This study examines adverse events in pediatric parenteral nutrition to prevent recurrence and enhance care quality.

Area of Science:

  • Healthcare Management
  • Patient Safety
  • Pediatric Care

Context:

  • Adverse events are a significant challenge in healthcare services.
  • Hospital authorities are responsible for analyzing and mitigating these events.
  • Ensuring the quality and safety of care requires continuous improvement.

Purpose:

  • To analyze adverse events in pediatric parenteral nutrition.
  • To identify corrective and preventive measures.
  • To prevent the recurrence of adverse events and improve care quality.

Summary:

  • This article focuses on the analysis of adverse events within pediatric parenteral nutrition.
  • It highlights the importance of corrective and preventive strategies.
  • The goal is to enhance the safety and quality of care provided to pediatric patients.

Impact:

  • Provides a framework for analyzing adverse events in specialized pediatric care.
  • Contributes to the sustainable improvement of healthcare quality and safety.
  • Offers insights into preventing adverse events in parenteral nutrition settings.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
74
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Types of Reports II: Incident or Occurrence Report01:21

Types of Reports II: Incident or Occurrence Report

An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
441
Guidelines and Strategies for Safe Computer Charting01:18

Guidelines and Strategies for Safe Computer Charting

The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
3.1K